Free Trial

Cipher Pharmaceuticals (CPH) Competitors

Cipher Pharmaceuticals logo
C$14.52 -0.41 (-2.75%)
As of 12:32 PM Eastern

CPH vs. CRON, THCX, DHT.UN, WEED, GUD, ACB, OGI, SUGR, FIRE, and EPI

Should you be buying Cipher Pharmaceuticals stock or one of its competitors? The main competitors of Cipher Pharmaceuticals include Cronos Group (CRON), Hydropothecary (THCX), DRI Healthcare Trust (DHT.UN), Canopy Growth (WEED), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Organigram (OGI), SugarBud Craft Growers (SUGR), Supreme Cannabis (FIRE), and ESSA Pharma (EPI). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Cipher Pharmaceuticals vs. Its Competitors

Cipher Pharmaceuticals (TSE:CPH) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

In the previous week, Cipher Pharmaceuticals had 7 more articles in the media than Cronos Group. MarketBeat recorded 7 mentions for Cipher Pharmaceuticals and 0 mentions for Cronos Group. Cipher Pharmaceuticals' average media sentiment score of 0.87 beat Cronos Group's score of 0.00 indicating that Cipher Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Cipher Pharmaceuticals Positive
Cronos Group Neutral

Cipher Pharmaceuticals has higher earnings, but lower revenue than Cronos Group. Cipher Pharmaceuticals is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cipher PharmaceuticalsC$47.59M7.75C$11.41MC$0.4631.57
Cronos GroupC$130.28M10.11-C$32.78MC$0.0568.80

3.2% of Cipher Pharmaceuticals shares are owned by institutional investors. Comparatively, 4.5% of Cronos Group shares are owned by institutional investors. 42.0% of Cipher Pharmaceuticals shares are owned by insiders. Comparatively, 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cipher Pharmaceuticals currently has a consensus target price of C$14.75, indicating a potential upside of 1.58%. Given Cipher Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts plainly believe Cipher Pharmaceuticals is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cipher Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Cipher Pharmaceuticals has a beta of 0.774739, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.299122, indicating that its share price is 30% more volatile than the S&P 500.

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cipher Pharmaceuticals59.92% 17.93% 7.90%
Cronos Group -42.65%-4.40%-3.73%

Summary

Cipher Pharmaceuticals beats Cronos Group on 9 of the 15 factors compared between the two stocks.

Get Cipher Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CPH vs. The Competition

MetricCipher PharmaceuticalsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$368.72MC$1.68BC$6.24BC$9.57B
Dividend YieldN/A2.95%5.74%6.52%
P/E Ratio31.578.7929.0628.89
Price / Sales7.751,629.69554.7510.95
Price / Cash3.5310.3737.4583.29
Price / Book3.6711.1612.325.58
Net IncomeC$11.41MC$20.70BC$3.32BC$301.20M
7 Day PerformanceN/A-1.72%-1.25%-3.03%
1 Month Performance-14.79%1.48%5.22%0.80%
1 Year Performance-11.63%8.13%61.35%31.48%

Cipher Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CPH
Cipher Pharmaceuticals
0.5799 of 5 stars
C$14.52
-2.7%
C$14.75
+1.6%
-9.5%C$368.72MC$47.59M31.575Analyst Revision
CRON
Cronos Group
N/AC$3.56
flat
N/A+17.8%C$1.36BC$130.28M71.20450
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
DHT.UN
DRI Healthcare Trust
N/AC$14.50
+0.3%
C$18.88
+30.2%
+1.6%C$804.76MC$139.45M207.14N/APositive News
High Trading Volume
WEED
Canopy Growth
0.17 of 5 stars
C$1.94
+1.6%
C$1.55
-20.1%
-68.3%C$605.26MC$274.92M-0.462,700
GUD
Knight Therapeutics
N/AC$5.74
-0.2%
C$7.15
+24.6%
+4.5%C$572.01MC$384.56M-21.70725Positive News
ACB
Aurora Cannabis
0.7268 of 5 stars
C$7.76
+0.9%
C$8.75
+12.8%
-5.6%C$436.47MC$357.88M-23.521,073
OGI
Organigram
3.0251 of 5 stars
C$2.72
+1.1%
C$3.33
+22.2%
-0.4%C$364.16MC$223.82M226.67987News Coverage
SUGR
SugarBud Craft Growers
N/AC$11.75
+4.3%
N/A+32.7%C$279.83MC$718.29M20.6044Gap Up
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725

Related Companies and Tools


This page (TSE:CPH) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners